Objective This study aimed to explore the prognostic value of mean platelet volume (MPV) in
patients with ovarian clear cell carcinoma (OCCC) and evaluate the predictive performance …

New studies show that inflammatory markers and blood cells may be related to epithelial
ovarian cancer (EOC). We aimed to examine whether mean platelet volume would be a …

Aim: Increasing evidence indicates that platelet count is a useful biomarker of long-term
outcomes in patients with ovarian cancer. However, the prognostic value of platelet count in …

BACKGROUND: Ovarian cancer (OC) is one of the most malignant gynecological cancers.
Platelets play a profound role in cancer growth and metastasis. Platelet distribution width …

Altered mean platelet volume (MPV) is found in several malignancies. Remarkably, there is
little consensus on using the value of MPV in the prognostic evaluations of renal cell …

Objective To determine whether preoperative platelets to lymphocyte ratio (PLR) could
predict disease stage, surgical outcome, and survival in patients with epithelial ovarian …

Background The majority of death-related ovarian cancer is epithelial ovarian cancer (EOC).
Regarding the Federation of Gynecology and Obstetrics (FIGO) stage IV EOC, the 5-year …

The platelet lymphocyte ratio (PLR) is an important prognostic biomarker in various cancers.
The current retrospective study was undertaken to determine the association between PLR …

Background The platelet‐to‐lymphocyte ratio (PLR) has been found to predict clinical
outcomes in borderline ovarian tumours and the other genital neoplasms. However, its …

Objectives: The platelet-to-lymphocyte ratio (PLR) is a predictive clinical biomarker for
different cancers. However, the results of several studies investigating the association …